Strong data hygiene, formal governance, and human oversight are becoming essential to responsible, scalable AI adoption in clinical trials.
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
ON-DEMAND WEBINARS
Edward Bartels, an expert in eCOA solutions, provides an in-depth overview of the market trends, emerging technologies, and how IQVIA eCOA is pioneering advancements in this space.
With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.
In this pre-recorded webinar, experts from the industry share real-world insights and practical guidance on how to achieve success in decentralized clinical trials.
Watch as clinical trial experts present how life science professionals can incorporate real-world data (RWD) and patient tokenization into their clinical development value streams.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Poor Protocol Design Is Costing You More Than Money]( "Why Amendments Break Trials and How Elosity R3 Fixes It")
Why Amendments Break Trials and How Elosity R3 Fixes ItProtocol amendments are inevitable. The challenge is managing them without disrupting trial execution.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Improving Clinical Trial Performance Through Central eSource")
Improving Clinical Trial Performance Through Central eSourceSee how a top five pharmaceutical company leveraged our esource platform to enhance site performance, improve data consistency, and enable remote monitoring.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
![GettyImages-1362491337 Nocturnal Scratch]( "Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch")
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal ScratchThe DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
-
![GettyImages-1081947082 clinical technology]( "Increase Participant Diversity With eClinical Tools")
Increase Participant Diversity With eClinical ToolsThe right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
![GettyImages-1391107099 nurse patient]( "4 Ways Home Visits Support Successful Rare Disease Clinical Trials")
4 Ways Home Visits Support Successful Rare Disease Clinical TrialsResearchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
![GettyImages-2234439798-AI-Medicine-Trials-Drug-Development]( "Why Trial Expertise Makes Or Breaks Clinical AI")
Why Trial Expertise Makes Or Breaks Clinical AIWhat makes AI effective in clinical trials? See how a top 5 pharma sponsor achieved a 62% reduction in CRA task time and 99% document classification accuracy by prioritizing clinical fluency.
-
![esource image]( "Why Research Sites Don't Use EMR As The Source Data Collection Tool")
Why Research Sites Don't Use EMR As The Source Data Collection ToolExamine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.
-
![GettyImages-1356381571 world data]( "Why Prospective Real-World Studies Hold Promise For Research")
Why Prospective Real-World Studies Hold Promise For ResearchClinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.
-
![GettyImages-1424406254 email marketing]( "Email: The Gold Standard For Clinical Trials")
Email: The Gold Standard For Clinical TrialsAlthough non-verbal conversations between friends are now primarily conducted through text messages or similar apps, see why email remains the standard mode for businesses and organizations.
RECENT NEWSLETTERS
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
